Libra Infusions Limited (DSE:LIBRAINFU)
630.80
-4.90 (-0.77%)
At close: Jan 20, 2026
Libra Infusions Revenue
In the fiscal year ending June 30, 2019, Libra Infusions had annual revenue of 197.03M BDT with 3.31% growth. Libra Infusions had revenue of 35.15M in the quarter ending March 31, 2019, a decrease of -49.69%.
Revenue
197.03M
Revenue Growth
-19.64%
P/S Ratio
7.15
Revenue / Employee
281.88K
Employees
699
Market Cap
1.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2019 | 197.03M | 6.31M | 3.31% |
| Jun 30, 2018 | 190.72M | -53.54M | -21.92% |
| Jun 30, 2017 | 244.26M | 6.11M | 2.57% |
| Jun 30, 2016 | 238.15M | -48.85M | -17.02% |
| Jun 30, 2015 | 287.00M | 4.69M | 1.66% |
| Jun 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Navana Pharmaceuticals | 9.52B |
| Techno Drugs | 3.23B |
| Orion Pharma | 3.23B |
| Asiatic Laboratories | 2.24B |
| Advent Pharma | 500.49M |
| Pharma Aids | 453.49M |
| Silco Pharmaceuticals | 428.63M |
| Silva Pharmaceuticals | 370.96M |